IE
CABA icon

Israel Englander’s Cabaletta Bio CABA Stock Holding History

Israel Englander’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.43M Sell
2,068,491
-3,834,790
-65% -$12.6M ﹤0.01% 2750
2026
Q1 		$15.9M Buy
5,903,281
+3,166,369
+116% +$8.79M 0.01% 1736
2025
Q4 		$5.99M Buy
2,736,912
+2,050,099
+298% +$5.08M ﹤0.01% 2813
2025
Q3 		$1.61M Sell
686,813
-168,517
-20% -$289K ﹤0.01% 4242
2025
Q2 		$1.3M Buy
855,330
+686,431
+406% +$1.07M ﹤0.01% 4225
2025
Q1 		$234K Sell
168,899
-342,714
-67% -$730K ﹤0.01% 5222
2024
Q4 		$1.16M Sell
511,613
-1,117,300
-69% -$3.92M ﹤0.01% 4081
2024
Q3 		$7.69M Buy
1,628,913
+930,596
+133% +$5.38M ﹤0.01% 2439
2024
Q2 		$5.22M Buy
698,317
+238,950
+52% +$2.93M ﹤0.01% 2680
2024
Q1 		$7.84M Buy
+459,367
New +$9.86M ﹤0.01% 2423
2023
Q3 		– Sell
-371,070
Closed -$4.79M – 6152
2023
Q2 		$4.79M Sell
371,070
-201,049
-35% -$2.18M ﹤0.01% 2714
2023
Q1 		$4.73M Buy
572,119
+220,994
+63% +$2.07M ﹤0.01% 2650
2022
Q4 		$3.25M Buy
351,125
+120,572
+52% +$439K ﹤0.01% 3152
2022
Q3 		$150K Sell
230,553
-7,683
-3% -$9.25K ﹤0.01% 5804
2022
Q2 		$253K Sell
238,236
-122,765
-34% -$174K ﹤0.01% 5501
2022
Q1 		$733K Buy
361,001
+218,864
+154% +$572K ﹤0.01% 4814
2021
Q4 		$539K Buy
142,137
+20,513
+17% +$219K ﹤0.01% 4982
2021
Q3 		$1.48M Sell
121,624
-868,706
-88% -$8.01M ﹤0.01% 4253
2021
Q2 		$8.52M Buy
990,330
+114,417
+13% +$1.12M 0.01% 2113
2021
Q1 		$9.72M Buy
875,913
+270,668
+45% +$3.31M 0.01% 1804
2020
Q4 		$7.55M Buy
605,245
+3,415
+0.6% +$44.3K 0.01% 2057
2020
Q3 		$6.52K Sell
601,830
-30,074
-5% -$346K 0.01% 1603
2020
Q2 		$7.04M Buy
631,904
+239,089
+61% +$1.83M 0.01% 1476
2020
Q1 		$2.87M Buy
392,815
+152,865
+64% +$2.1M 0.01% 1762
2019
Q4 		$3.35M Buy
+239,950
New +$2.84M ﹤0.01% 2239

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Israel Englander's CABA Position: Q2 2026 in Review

Israel Englander reduced its Cabaletta Bio (CABA) stake by 65% in Q2 2026, selling an estimated $12.6M and leaving 2,068,491 shares worth $6.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Israel Englander first reported a position in CABA in Q4 2019 and has held it in 25 quarters since. The position peaked at $15.9M in Q1 2026. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Israel Englander held 2,068,491 shares of Cabaletta Bio worth $6.43M as of Q2 2026.
  • Israel Englander sold 3,834,790 Cabaletta Bio shares in Q2 2026, an estimated $12.6M.
  • Cabaletta Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2750 holding.
  • Israel Englander first reported a position in Cabaletta Bio in Q4 2019 and has held it in 25 quarters since.
  • Israel Englander's Cabaletta Bio position peaked at $15.9M in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.